1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.96%
Positive revenue growth while WEED.TO is negative. John Neff might see a notable competitive edge here.
-116.90%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
1962.12%
EBIT growth above 1.5x WEED.TO's 233.68%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
1962.12%
Operating income growth above 1.5x WEED.TO's 233.68%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-1159.97%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-1118.10%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-1118.10%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
4.74%
Share count expansion well above WEED.TO's 4.08%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
4.12%
Diluted share count expanding well above WEED.TO's 4.08%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
55.76%
OCF growth above 1.5x WEED.TO's 2.89%. David Dodd would confirm a clear edge in underlying cash generation.
48.79%
FCF growth above 1.5x WEED.TO's 2.22%. David Dodd would verify if the firm’s strategic investments yield superior returns.
No Data
No Data available this quarter, please select a different quarter.
773.51%
5Y revenue/share CAGR at 50-75% of WEED.TO's 1386.77%. Martin Whitman would worry about a lagging mid-term growth trajectory.
-31.54%
Negative 3Y CAGR while WEED.TO stands at 463.58%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-3473.12%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-20076.82%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
36.10%
Positive 3Y OCF/share CAGR while WEED.TO is negative. John Neff might see a big short-term edge in operational efficiency.
-17455.75%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-5049.26%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-1634.83%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
8676.79%
10Y equity/share CAGR above 1.5x WEED.TO's 2848.92%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
394.53%
5Y equity/share CAGR above 1.5x WEED.TO's 153.53%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
44.47%
3Y equity/share CAGR above 1.5x WEED.TO's 7.84%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.62%
Our AR growth while WEED.TO is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-10.16%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-6.35%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-9.02%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-14.88%
We’re deleveraging while WEED.TO stands at 8.40%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-67.07%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
3.79%
We expand SG&A while WEED.TO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.